First Trust Advisors LP raised its holdings in shares of Ingevity Corporation (NYSE:NGVT – Free Report) by 11.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 116,699 shares of the company’s stock after buying an additional 12,200 shares during the period. First Trust Advisors LP’s holdings in Ingevity were worth $8,312,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of NGVT. Dimensional Fund Advisors LP increased its holdings in shares of Ingevity by 3.0% in the first quarter. Dimensional Fund Advisors LP now owns 798,709 shares of the company’s stock worth $56,889,000 after buying an additional 23,219 shares during the period. Assetmark Inc. boosted its holdings in Ingevity by 9.6% during the 1st quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock valued at $113,000 after acquiring an additional 139 shares during the period. Bessemer Group Inc. boosted its holdings in Ingevity by 465.9% during the 1st quarter. Bessemer Group Inc. now owns 314,739 shares of the company’s stock valued at $22,419,000 after acquiring an additional 259,124 shares during the period. Frazier Financial Advisors LLC bought a new position in Ingevity during the 1st quarter worth approximately $71,000. Finally, Illinois Municipal Retirement Fund bought a new position in Ingevity during the 1st quarter worth approximately $1,465,000. 91.59% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the sale, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.88% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Research Report on NGVT
Ingevity Stock Performance
Shares of NYSE:NGVT opened at $73.16 on Friday. The company has a current ratio of 1.61, a quick ratio of 0.92 and a debt-to-equity ratio of 22.52. The company has a 50-day moving average price of $71.76 and a 200-day moving average price of $70.97. The company has a market cap of $2.54 billion, a price-to-earnings ratio of 49.77 and a beta of 1.16. Ingevity Corporation has a 12 month low of $39.74 and a 12 month high of $79.29.
Ingevity (NYSE:NGVT – Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.The company had revenue of $314.10 million for the quarter, compared to analysts’ expectations of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, equities analysts anticipate that Ingevity Corporation will post 5.05 EPS for the current year.
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Stories
- Five stocks we like better than Ingevity
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
